Months after going public, Peninsula biotech Apexigen cuts staff, weighs its options for future
February 27, 2023 at 17:29 PM EST
The company ended last year with enough cash to last into third-quarter 2022.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |